Acute Joint Pain

History Taking

3 minutes
28 marks

Task Instruction:

Scenario: A 52-year-old man presents to the Emergency Department at 3 AM with sudden onset of severe pain, swelling, and redness in his right big toe. He rates the pain as 9/10 and says he cannot bear any weight on the foot. The pain woke him from sleep about 4 hours ago.

Your task: Take a comprehensive history from this patient.

Logo
🎙️
Audio Recording
REC
00:00

Physical Examination

2 minutes
26 marks

Task Instruction:

Information from History: 52-year-old man with sudden onset severe pain in right first MTP joint that woke him from sleep. Reports swelling, redness, and inability to bear weight. Had a celebratory dinner with steak and wine yesterday. Has history of hypertension on thiazide diuretic. No fever reported.

Your task: Perform a focused and systematic musculoskeletal examination of the affected joint and relevant systems.

Logo
🎙️
Audio Recording
REC
00:00

History & Exam Knowledge

2 minutes
4 questions

Knowledge Check:

Test your understanding of the key clinical features, pathophysiology, and examination findings in acute monoarthritis and crystal arthropathies. Click each question to reveal the answer.

Q1: What are the classic clinical features of acute gout and why does it typically affect the first MTP joint?
  • Classic features (4 cardinal signs): Sudden onset of severe pain (often nocturnal), marked swelling, intense erythema (can extend beyond joint), and warmth with exquisite tenderness (even bedsheet contact is painful).
  • Podagra predilection: The first MTP joint is affected in >50% of initial attacks due to lower temperature (urate crystallizes more readily in cooler peripheral joints), increased mechanical stress, and lower tissue pH from anaerobic metabolism.
  • Timing pattern: Attacks often occur at night because nocturnal dehydration concentrates urate, and recumbent position decreases joint temperature further.
  • Natural course: Untreated attacks typically self-resolve within 7-14 days, but early treatment significantly shortens duration and severity.
Q2: What are the key risk factors for gout and which medications can precipitate acute attacks?
  • Non-modifiable risk factors: Male sex (9:1 ratio), age >40 years, post-menopausal women, genetic predisposition, ethnicity (Pacific Islanders, Māori).
  • Modifiable risk factors: Obesity, metabolic syndrome, hypertension, chronic kidney disease, high-purine diet (red meat, organ meats, shellfish), alcohol (especially beer), fructose-sweetened beverages.
  • Medications causing hyperuricemia: Thiazide and loop diuretics, low-dose aspirin (<2g/day), cyclosporine, tacrolimus, pyrazinamide, ethambutol, nicotinic acid.
  • Attack triggers: Sudden changes in urate levels (starting/stopping allopurinol), dehydration, surgery, trauma, acute illness, excessive alcohol or dietary indiscretion.
Q3: What are tophi and where are they commonly found on physical examination?
  • Definition: Tophi are deposits of monosodium urate crystals surrounded by chronic granulomatous inflammation, occurring in patients with prolonged hyperuricemia (typically >10 years of untreated disease).
  • Classic locations: Helix and antihelix of ears, olecranon bursae, finger pulps and DIP joints, Achilles tendon, prepatellar bursa, first MTP joint.
  • Clinical characteristics: Firm, irregular, chalky-white or yellowish nodules; may discharge white chalky material (urate); can cause joint destruction and deformity; occasionally ulcerate through skin.
  • Clinical significance: Presence of tophi indicates chronic tophaceous gout requiring urate-lowering therapy with target serum urate <300 μmol/L (<5 mg/dL) for dissolution.
Q4: How do you clinically differentiate acute gout from septic arthritis, and when should you suspect septic arthritis?
  • Overlapping features: Both present with acute monoarthritis, joint swelling, erythema, warmth, and severe pain – clinical differentiation can be extremely difficult.
  • Favors gout: Previous similar episodes, known hyperuricemia, dietary/alcohol trigger, first MTP joint, self-limited course, no fever, rapid response to NSAIDs/colchicine.
  • Red flags for septic arthritis: Fever/rigors, immunocompromised state, recent joint procedure/surgery, overlying skin breach, prosthetic joint, IV drug use, failure to respond to gout treatment, very high inflammatory markers.
  • Critical point: Joint aspiration is mandatory if septic arthritis cannot be excluded – septic arthritis is an orthopedic emergency requiring urgent surgical washout and IV antibiotics. Gout and septic arthritis can coexist.

Differential Diagnosis

2 minutes
20 marks

Task Instruction:

Clinical Summary: 52-year-old man with sudden onset severe pain, swelling, and erythema of the right first MTP joint that woke him from sleep. History of hypertension on thiazide diuretic. Had steak and wine dinner yesterday. Examination reveals exquisitely tender, swollen, erythematous first MTP joint with overlying shiny skin. Afebrile. No other joints involved.

Your task: Present your differential diagnoses in order of likelihood, justifying your clinical reasoning for each.

Logo
🎙️
Audio Recording
REC
00:00

Investigations

2 minutes
18 marks

Task Instruction:

Working Diagnosis: Acute gout (crystal arthropathy) affecting the right first MTP joint, with septic arthritis as an important differential to exclude.

Your task: Outline the investigations you would request, explaining the rationale for each and what findings you would expect.

Logo
🎙️
Audio Recording
REC
00:00

Investigation Knowledge

2 minutes
4 questions

Knowledge Check:

Test your understanding of the investigations used in diagnosing and managing crystal arthropathies. Click each question to reveal the answer.

Q1: What is the difference between monosodium urate (MSU) crystals in gout and calcium pyrophosphate (CPP) crystals in pseudogout under polarized light microscopy?
  • MSU crystals (Gout): Needle-shaped crystals that are negatively birefringent - they appear yellow when parallel to the axis of the red compensator and blue when perpendicular ("yellow parallel").
  • CPP crystals (Pseudogout): Rhomboid or rod-shaped crystals that are weakly positively birefringent - they appear blue when parallel to the axis and yellow when perpendicular ("blue parallel").
  • Clinical pearl: MSU crystals are typically easier to identify due to stronger birefringence; CPP crystals can be easily missed due to weak birefringence and require careful examination.
  • Mnemonic: "Gout is Negative and Needle-shaped" - both start with N.
Q2: Why might serum uric acid be normal or even low during an acute gout attack, and when should it be measured?
  • Paradoxical drop: During acute inflammation, uric acid is consumed in the inflammatory process, uricosuric cytokines are released, and renal excretion increases - serum levels can drop by 1-2 mg/dL.
  • Diagnostic pitfall: Up to 40% of patients have normal serum urate during acute attacks; a normal level does NOT exclude gout.
  • Optimal timing: Serum urate should be measured 2-4 weeks after the acute attack has resolved for accurate baseline assessment and to guide urate-lowering therapy decisions.
  • Threshold for hyperuricemia: Serum urate >7 mg/dL (>420 μmol/L) in men or >6 mg/dL (>360 μmol/L) in women is considered hyperuricemia, though crystallization can occur at lower levels.
Q3: What synovial fluid findings would make you concerned about septic arthritis rather than gout?
  • WBC count threshold: Synovial WBC >50,000/μL is highly suspicious for septic arthritis (though gout can occasionally reach this level); >100,000/μL is strongly suggestive of infection.
  • Gram stain: Positive Gram stain is diagnostic but only 50-75% sensitive; a negative Gram stain does not exclude septic arthritis.
  • Fluid appearance: Purulent (thick, opaque, creamy) fluid is more concerning for infection than the cloudy inflammatory fluid of gout.
  • Critical point: Crystals and bacteria can coexist - finding urate crystals does NOT exclude concurrent infection. If clinical suspicion is high, treat for both while awaiting culture results.
Q4: What are the characteristic X-ray findings in chronic tophaceous gout and how do they differ from rheumatoid arthritis?
  • Gout X-ray features: "Punched-out" erosions with overhanging edges (Martel's sign), preserved joint space until late disease, asymmetric distribution, soft tissue tophi with occasional calcification, periarticular bone density preserved.
  • RA X-ray features: Marginal erosions without overhanging edges, early joint space narrowing, periarticular osteopenia, symmetric and polyarticular distribution, no tophi.
  • Key differentiator: Gout erosions have characteristic "rat-bite" appearance with sclerotic margins and overhanging cortical bone; RA erosions are more ill-defined with osteopenic bone.
  • Early gout: Plain X-rays are often normal in early or acute gout; ultrasound (double contour sign) or DECT are more sensitive for early diagnosis.

Management Plan

2 minutes
22 marks

Task Instruction:

Confirmed Diagnosis: Acute gout affecting the right first MTP joint, confirmed by joint aspiration showing negatively birefringent needle-shaped monosodium urate crystals. Gram stain negative. Patient has hypertension (on thiazide), eGFR 65 mL/min, and no history of peptic ulcer disease.

Your task: Present a comprehensive management plan for this patient, including acute treatment, long-term management, and patient education.

Logo
🎙️
Audio Recording
REC
00:00

Management Knowledge

2 minutes
4 questions

Knowledge Check:

Test your understanding of gout management principles, drug mechanisms, and special situations. Click each question to reveal the answer.

Q1: Why do patients often experience gout flares when starting urate-lowering therapy, and how can this be prevented?
  • Mechanism of paradoxical flares: When serum urate drops rapidly, existing urate crystal deposits begin to dissolve; this mobilization releases crystals into the joint space, triggering acute inflammation.
  • Crystal shedding: As tophi and microtophi shrink, previously "silent" crystals are shed into the synovium, activating the NLRP3 inflammasome and IL-1β release.
  • Prevention strategies: Start ULT at low dose and titrate slowly ("start low, go slow"); co-prescribe prophylactic low-dose colchicine (500mcg daily-BD) or low-dose NSAID for 3-6 months.
  • Patient counseling: Warn patients that flares may occur initially but will decrease over time; emphasize continuing ULT during flares (stopping and starting worsens the cycle).
Q2: What is allopurinol hypersensitivity syndrome (AHS) and what are the risk factors?
  • Clinical features: Severe cutaneous adverse reaction (SCAR) including DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN); mortality rate 20-30%.
  • Presentation: Typically occurs 2-8 weeks after starting; features fever, rash (often morbilliform progressing to exfoliative), eosinophilia, hepatitis, nephritis, and multi-organ involvement.
  • Risk factors: HLA-B*5801 allele (especially in Han Chinese, Thai, Korean populations - screening recommended), renal impairment, high starting dose, concurrent thiazide diuretics.
  • Prevention: Screen high-risk populations for HLA-B*5801; start at 100mg daily (50mg if eGFR <30); titrate slowly; avoid in acute flares without anti-inflammatory cover; educate patients to stop immediately if rash develops.
Q3: What are the mechanisms of action of allopurinol and febuxostat, and how do they differ from uricosuric agents?
  • Xanthine oxidase inhibitors (allopurinol, febuxostat): Block xanthine oxidase enzyme, preventing conversion of hypoxanthine → xanthine → uric acid; reduce urate production at the source; first-line therapy.
  • Allopurinol specifics: Purine analogue; active metabolite oxypurinol; dose adjustment needed in renal impairment; risk of hypersensitivity syndrome.
  • Febuxostat specifics: Non-purine selective XO inhibitor; metabolized hepatically (no renal dose adjustment); associated with increased cardiovascular mortality in CARES trial - use with caution in CVD.
  • Uricosurics (probenecid, benzbromarone, lesinurad): Increase renal urate excretion by inhibiting URAT1 transporter; require adequate renal function (eGFR >30-50); contraindicated in urolithiasis; require high fluid intake; rarely used as monotherapy.
Q4: How should acute gout be managed in a patient with chronic kidney disease (CKD stage 4, eGFR 20)?
  • NSAIDs: Generally contraindicated in advanced CKD due to risk of further renal deterioration, fluid retention, and hyperkalemia; avoid if possible.
  • Colchicine: Can be used but requires significant dose reduction (0.5mg once daily or every other day); accumulates in renal impairment causing toxicity (myopathy, bone marrow suppression); avoid with concurrent CYP3A4 inhibitors.
  • Corticosteroids: Preferred option in CKD - oral prednisolone 30-35mg daily for 5 days; intra-articular injection if single joint; or IM/IV methylprednisolone if oral not possible.
  • IL-1 inhibitors: Anakinra (off-label) or canakinumab reserved for refractory cases when NSAIDs, colchicine, and steroids are contraindicated or ineffective; effective but expensive.
  • ULT in CKD: Allopurinol can be used but start very low (50mg daily or every other day) and titrate cautiously; febuxostat is an alternative as it doesn't require renal dose adjustment.

One-Page OSCE Guide

Study Guide

Overall OSCE Performance

Acute Joint Pain Station
0%
--
GRADE
0
EARNED
114
TOTAL
Task 1: History
0 /28 0%
Task 2: Exam
0 /26 0%
Task 4: DDx
0 /20 0%
Task 5: Ix
0 /18 0%
Task 7: Mx
0 /22 0%
Complete Tasks 1, 2, 4, 5, and 7 to see your overall OSCE performance!

1. 60-Second Cram Sheet ⚡

⏰ Read this 2 minutes before entering the station!

Opening (30 seconds)

  • Wash hands, introduce yourself, confirm patient identity
  • Open with: "I understand you have severe pain in your toe. Can you tell me more about what happened?"
  • Show empathy: Acknowledge the severe pain - "That sounds extremely painful"

History Taking Must-Asks

  • SOCRATES for pain - especially onset (sudden, nocturnal), site (1st MTP), severity (exquisite)
  • Triggers: Alcohol (beer/wine), red meat, seafood, dehydration, new medications
  • Medications: Diuretics (thiazides, furosemide), low-dose aspirin, cyclosporine
  • Red flags: Fever, multiple joints, immunosuppression, prosthetic joint
  • PMH: Previous attacks, kidney disease, kidney stones, hypertension, diabetes

Examination Essentials

  • Look: Compare both feet - swelling, erythema, shiny skin over 1st MTP
  • Feel: Warmth (dorsum of hand), exquisite tenderness, soft tissue swelling
  • Move: Limited by pain - be gentle!
  • Don't forget: Check ears, elbows, Achilles for tophi
  • Screen: Other joints (knees, ankles, wrists) for polyarticular involvement

Diagnosis & Management

  • Gold standard: Joint aspiration → negatively birefringent needle-shaped MSU crystals
  • Acute treatment: NSAIDs (naproxen 500mg BD) OR colchicine OR prednisolone
  • Key point: Serum urate may be NORMAL during acute attack!
  • Long-term: Allopurinol (start low, go slow) with colchicine prophylaxis

🧠 Essential Mnemonics

GOUT Risk Factors = "GOUT CAUSES"

  • G - Genetics / Gender (male)
  • O - Obesity
  • U - Urate overproduction / Underexcretion
  • T - Thiazides / diuretics
  • C - Chronic kidney disease
  • A - Alcohol (especially beer)
  • U - Uric acid rich foods (meat, seafood)
  • S - Sugar (fructose) sweetened drinks
  • E - Elderly / Ethnicity (Pacific Islander)
  • S - Surgery / Stress / Starvation

Crystal Identification = "Gout is Negative and Needle-shaped"

  • Gout (MSU): Needle-shaped, Negatively birefringent, Yellow when parallel
  • Pseudogout (CPPD): Rhomboid-shaped, Positively birefringent (weak), Blue when parallel

Acute Gout Treatment = "Nice Cold Pints"

  • N - NSAIDs (first-line if no contraindications)
  • C - Colchicine (alternative, watch for GI side effects)
  • P - Prednisolone / steroids (if NSAIDs/colchicine contraindicated)

ULT Initiation = "Start Low, Go Slow"

  • Start: Allopurinol 100mg daily (50mg if CKD)
  • Titrate: Increase by 100mg every 2-4 weeks
  • Target: Serum urate <360 μmol/L (<300 if tophi)
  • Prophylaxis: Colchicine 500mcg daily for 3-6 months

⚡ Quick Reference: Gout vs Pseudogout vs Septic Arthritis

Feature Gout Pseudogout Septic Arthritis
Typical Joint 1st MTP (podagra) Knee, wrist Knee, hip
Age Group 40-60 years, male >65 years Any age
Onset Sudden (hours) Acute to subacute Rapid (hours-days)
Fever Usually absent Low-grade possible Usually present
Crystals MSU (negative, needle) CPPD (positive, rhomboid) None
Synovial WBC 10,000-50,000/μL 10,000-50,000/μL >50,000/μL

2. Common Pitfalls & Red Flags NOT to Miss

Common Mistakes in OSCE

  • Assuming normal urate excludes gout: Serum urate drops during acute attacks - up to 40% have normal levels
  • Forgetting to exclude septic arthritis: Always consider joint aspiration if diagnosis uncertain or red flags present
  • Starting allopurinol during acute attack without cover: Can worsen/prolong flare - needs anti-inflammatory prophylaxis
  • Not examining for tophi: Check ears, elbows, fingers, Achilles - indicates chronic disease
  • Ignoring comorbidities: Screen for metabolic syndrome, CKD, cardiovascular disease
  • Not asking about medications: Thiazides, low-dose aspirin, cyclosporine are key triggers
  • Forgetting dietary/alcohol history: Recent beer, red meat, seafood are classic triggers
  • Starting allopurinol at high dose: Start low (100mg), go slow - reduces hypersensitivity risk

Critical Red Flags

Red Flag What It Suggests / Action Required
Fever with hot joint Septic arthritis until proven otherwise - urgent joint aspiration, Gram stain, culture; consider IV antibiotics
Immunocompromised patient Higher risk of septic arthritis; lower threshold for aspiration; atypical organisms possible
Prosthetic joint involvement Prosthetic joint infection is emergency - urgent orthopedic referral; may need surgical washout
Overlying skin break/wound Portal of entry for infection - increases septic arthritis risk; examine carefully for cellulitis
Failure to respond to treatment Reconsider diagnosis - may be septic arthritis, CPPD, or dual pathology; repeat aspiration
Multiple joints + systemic symptoms Consider disseminated gonococcal infection, reactive arthritis, rheumatoid arthritis, viral arthritis
Recent joint procedure/injection Iatrogenic septic arthritis risk - aspiration and culture mandatory
IV drug use High risk for septic arthritis (including atypical joints like sternoclavicular); blood cultures essential

When to Perform Joint Aspiration

  • First presentation: To confirm crystal diagnosis and exclude infection
  • Diagnostic uncertainty: When clinical picture is atypical or unclear
  • Suspected septic arthritis: Any red flags present - fever, immunosuppression, prosthesis
  • Failure to respond: To reassess if not improving with appropriate treatment
  • Therapeutic benefit: Aspiration alone can provide significant pain relief
  • Remember: Gout and septic arthritis CAN coexist - finding crystals doesn't exclude infection

3. Clinical Reasoning Framework

Diagnostic Approach

STEP 1: Characterize the Arthritis

  • Monoarticular vs polyarticular: Gout typically monoarticular initially; polyarticular suggests RA, viral, or chronic gout
  • Acute vs chronic: Gout has dramatic acute onset (peak within 24 hours); RA is more gradual
  • Inflammatory vs mechanical: Gout is inflammatory (red, hot, swollen, severe pain); OA is mechanical (worse with use)
  • Distribution pattern: Gout favors lower limb peripherally (1st MTP > ankle > knee)

STEP 2: Assess Clinical Probability

High Probability for Gout Lower Probability / Consider Alternatives
Male patient aged 40-60 Premenopausal woman (rare in this group)
First MTP joint involvement (podagra) Large joint as first presentation (consider CPPD)
Sudden onset, nocturnal, peak <24h Gradual onset over days-weeks
Clear dietary/alcohol trigger Recent GI/GU infection (reactive arthritis)
History of similar self-limiting episodes First episode with fever (exclude septic)
On thiazide diuretic or low-dose aspirin Rash, nail changes (psoriatic arthritis)

Comprehensive Differential Diagnosis Table

Condition Key Clinical Features Examination Findings Investigations Key Differentiators
Acute Gout Sudden onset, nocturnal, excruciating pain, 1st MTP most common, dietary/alcohol trigger, male predominance Exquisite tenderness, erythema extending beyond joint, warmth, swelling, tophi (chronic), afebrile usually Negatively birefringent needle-shaped crystals, elevated WBC in fluid, serum urate may be normal Podagra, clear trigger, rapid response to NSAIDs/colchicine, self-limiting
Septic Arthritis Fever, rigors, rapid onset, single hot joint, risk factors (DM, immunosuppression, IVDU, prosthesis) Fever, toxic appearance, severely restricted ROM, joint held in flexion, overlying cellulitis possible Synovial WBC >50,000/μL, positive Gram stain (50-75%), positive culture, elevated CRP/WCC Fever + hot joint, systemic toxicity, risk factors, orthopedic emergency
Pseudogout (CPPD) Elderly patient (>65), knee/wrist most common, acute or chronic, associated with OA, metabolic conditions Similar to gout but larger joints, may have OA changes, less dramatic erythema, low-grade fever possible Positively birefringent rhomboid crystals (weak), chondrocalcinosis on X-ray Older age, large joints, X-ray chondrocalcinosis, crystal morphology
Reactive Arthritis Preceding infection (1-4 weeks prior) - urethritis, diarrhea; young adults, asymmetric oligoarthritis Large joint involvement, enthesitis (Achilles), dactylitis, conjunctivitis, keratoderma, circinate balanitis Sterile joint fluid, HLA-B27 positive (50-80%), stool/urethral cultures, elevated inflammatory markers Preceding GI/GU infection, extra-articular features, young patient
Psoriatic Arthritis Psoriasis history (may be subtle - scalp, nails, natal cleft), DIP involvement, dactylitis, asymmetric Nail pitting/onycholysis, skin plaques, "sausage digits" (dactylitis), enthesitis, DIP swelling RF negative, pencil-in-cup deformity on X-ray, periostitis, negative crystals Skin/nail changes, DIP involvement, dactylitis, family history
Cellulitis Spreading erythema, skin warmth, may have portal of entry (wound, tinea pedis), fever common Ill-defined erythema spreading beyond joint, skin tenderness, lymphangitis, regional lymphadenopathy Elevated WCC/CRP, blood cultures if systemic, joint aspiration normal if no septic arthritis Spreading skin infection, not joint-centered, portal of entry, lymphangitis
OA Flare Known OA, gradual worsening, mechanical pain pattern, older patient, weight-bearing joints Bony swelling, crepitus, mild warmth, Heberden's/Bouchard's nodes, reduced ROM Non-inflammatory fluid (<2000 WBC), joint space narrowing, osteophytes, subchondral sclerosis on X-ray Mechanical symptoms, less acute, bony changes, older patient
Rheumatoid Arthritis Symmetrical polyarthritis, small joints (MCP, PIP, wrists), morning stiffness >1 hour, gradual onset Symmetrical swelling, MCP/PIP/wrist involvement, boggy synovitis, later deformities (swan neck, boutonniere) RF positive (70%), Anti-CCP positive (more specific), elevated ESR/CRP, erosions on X-ray Symmetrical, polyarticular, morning stiffness, RF/Anti-CCP positive

STEP 3: Risk Stratify for Septic Arthritis

  • High risk - aspirate urgently: Fever, immunosuppression, prosthetic joint, recent procedure, IVDU, skin break
  • Moderate risk - consider aspiration: First presentation, atypical features, failure to respond to gout treatment
  • Lower risk - clinical diagnosis acceptable: Classic presentation, known gout, clear trigger, rapid NSAID response, afebrile
  • Remember: When in doubt, aspirate - it's diagnostic AND therapeutic

STEP 4: Formulate Management Plan

Phase Treatment Options Key Considerations
Acute Flare NSAIDs, Colchicine, Corticosteroids Start within 24h; consider renal function, GI history, diabetes
Prophylaxis Low-dose colchicine or NSAID When starting ULT; continue 3-6 months
Urate-Lowering Allopurinol (1st line), Febuxostat Start low, titrate to target <360 μmol/L
Lifestyle Diet, alcohol, weight, hydration Adjunct to pharmacotherapy; modest effect alone

Evidence-Based Management Pearls

  • NSAIDs vs Colchicine vs Steroids: Similar efficacy for acute gout; choice based on contraindications and patient factors
  • Colchicine dosing: Low-dose regimen (1.2mg then 0.6mg one hour later) as effective as high-dose with fewer GI side effects
  • Intra-articular steroids: Excellent option for monoarticular gout, especially if systemic therapy contraindicated
  • ULT during acute attack: Recent guidelines support starting during flare with anti-inflammatory cover (improves adherence)
  • Febuxostat caution: CARES trial showed increased CV mortality vs allopurinol - use with caution in CVD patients
  • Treat-to-target: Titrate ULT to achieve serum urate <360 μmol/L (or <300 if tophi) - not a fixed dose

4. OSCE Station Variants

Station Formats

Variant 1: History Taking Station

Format: 52-year-old man with acute toe pain - take a focused history

Key focus: SOCRATES for pain, triggers (alcohol, diet, medications), risk factors, previous episodes, comorbidities (CKD, HTN, CVD), red flags for septic arthritis

Variant 2: Physical Examination Station

Format: Examine this patient's foot/perform a musculoskeletal examination

Key focus: Systematic Look-Feel-Move of affected joint, compare sides, check for tophi (ears, elbows, Achilles), screen other joints, assess for chronic changes

Variant 3: Patient Counseling Station

Format: Explain the diagnosis of gout and management plan to the patient

Key focus: Explain what gout is (crystal deposition), acute treatment options, lifestyle modifications (alcohol, diet), long-term ULT rationale, flare action plan, importance of adherence

Variant 4: Data Interpretation / Viva Station

Format: Interpret synovial fluid results, X-ray findings, or discuss investigation results

Key focus: Crystal identification (MSU vs CPPD), synovial fluid analysis (WBC count, Gram stain), X-ray features (punched-out erosions vs chondrocalcinosis), serum urate interpretation

Variant 5: Acute Management Station

Format: Patient with acute gout - outline immediate management

Key focus: Analgesia choice (NSAID vs colchicine vs steroid), dosing, contraindications assessment (renal function, GI history), supportive measures (rest, ice, elevation), safety-netting

Variant 6: Complex/Atypical Case

Format: NOT a straightforward first presentation of podagra

Atypical Presentation Clinical Implication
Polyarticular gout More common in chronic/tophaceous gout; wider differential (RA, viral); may need multiple joint aspirations
Gout in young woman Rare - consider secondary causes (CKD, myeloproliferative, inherited enzyme defects); investigate thoroughly
Gout with fever Must exclude septic arthritis - joint aspiration mandatory; can have dual pathology
Gout in CKD patient Treatment modifications needed - avoid/reduce NSAIDs, adjust colchicine dose, careful ULT titration
Post-operative gout flare Common trigger; must differentiate from wound infection or septic arthritis; steroids often safest option
Gout with prosthetic joint nearby Low threshold for aspiration of prosthetic joint if any concern; orthopedic involvement early
Tophaceous gout Indicates chronic undertreated disease; aggressive ULT needed (target urate <300 μmol/L); may need surgical debulking
Allopurinol hypersensitivity DRESS/SJS/TEN - stop immediately; supportive care; febuxostat may be cautiously trialed later (some cross-reactivity)

Universal Tips for All Variants

  • Always consider septic arthritis: It's the "can't miss" diagnosis - mention aspiration if any diagnostic uncertainty
  • Know your drug contraindications: NSAIDs (CKD, PUD, CVD), Colchicine (severe renal/hepatic), Allopurinol (hypersensitivity risk factors)
  • Serum urate pitfall: Always mention it can be normal during acute attacks - don't let a normal level exclude the diagnosis
  • Address comorbidities: Gout patients often have metabolic syndrome - mention CV risk, diabetes screening, renal monitoring
  • Patient education: Explain chronic nature, importance of ULT adherence, continuing ULT during flares, lifestyle modifications
  • Medication review: Always ask about/consider stopping thiazides, low-dose aspirin if alternatives exist
  • Flare action plan: Patients should have medications at home to start treatment early when flares occur
  • Follow-up: Arrange review for serum urate check (2-4 weeks after flare), ULT initiation discussion, comorbidity management

Common Scenario Decision Matrix

Clinical Scenario Management Decision
Classic podagra, afebrile, known gout, clear trigger Clinical diagnosis acceptable; start NSAIDs/colchicine; aspiration optional
First presentation, typical features, no red flags Aspiration recommended to confirm diagnosis; start treatment empirically while awaiting results
Hot swollen joint with fever Urgent joint aspiration - septic arthritis until proven otherwise; consider empirical antibiotics
Gout in patient with eGFR 25 Avoid NSAIDs; low-dose colchicine (0.5mg daily/every other day) or prednisolone; careful ULT dosing
Gout in patient with active peptic ulcer Avoid NSAIDs; colchicine or prednisolone preferred; intra-articular steroid excellent option
Patient on warfarin with acute gout Colchicine safest (but check interactions); prednisolone; avoid NSAIDs (INR interaction + bleeding risk)
Recurrent attacks despite allopurinol 300mg Check compliance and serum urate; titrate allopurinol upward (can go to 800-900mg); ensure target achieved
Patient develops rash on allopurinol Stop immediately; mild rash - may rechallenge cautiously; severe/systemic - never rechallenge, use febuxostat
Starting ULT - how to prevent flares Start low dose, titrate slowly; prophylactic colchicine 0.5mg daily or low-dose NSAID for 3-6 months
Patient asks about diet alone for gout control Diet helps but modest effect (10-15% urate reduction); pharmacotherapy usually needed; diet is adjunct